日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Machine learning models for pancreatic cancer diagnosis based on microbiome markers from serum extracellular vesicles

基于血清细胞外囊泡微生物组标志物的胰腺癌诊断机器学习模型

Lee, Doeun; Lee, Chanhee; Han, Kyulhee; Goo, Taewan; Kim, Boram; Han, Youngmin; Kwon, Wooil; Lee, Seungyeoun; Jang, Jin-Young; Park, Taesung

The Poly (ADP-ribose) polymerase inhibitor olaparib and pan-ErbB inhibitor neratinib are highly synergistic in HER2 overexpressing epithelial ovarian carcinoma in vitro and in vivo

聚(ADP-核糖)聚合酶抑制剂奥拉帕尼和泛 ErbB 抑制剂来那替尼在体外和体内对 HER2 过度表达的上皮性卵巢癌具有高度协同作用

Chanhee Han, Blair McNamara, Stefania Bellone, Justin Harold, Paola Manara, Tobias Max Philipp Hartwich, Levent Mutlu, Yang Yang-Hartwich, Margherita Zipponi, Cem Demirkiran, Miguel Skyler Z Verzosa, Gary Altwerger, Elena Ratner, Gloria S Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter R

Highly Reliable Flexible Device with a Charge Compensation Layer

具有电荷补偿层的高可靠性柔性器件

Hyojung Kim, Jongwoo Park, Taeyoung Khim, Jungmin Park, Chanhee Han, Jongmin Yoo, Dongbhin Kim, Jangkun Song, Byoungdeog Choi

Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma

HUWE1/c-MYC 通路紊乱导致宫颈癌对 BET 溴结构域抑制剂 GS-626510 敏感

Elena Bonazzoli, Stefania Bellone, Luca Zammataro, Barbara Gnutti, Adele Guglielmi, Silvia Pelligra, Nupur Nagarkatti, Paola Manara, Joan Tymon-Rosario, Burak Zeybek, Gary Altwerger, Gulden Menderes, Chanhee Han, Elena Ratner, Dan-Arin Silasi, Gloria S Huang, Vaagn Andikyan, Masoud Azodi, Peter E Sc

In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma

针对子宫浆液性癌滋养层细胞表面抗原 2 (Trop-2) 的抗体-药物偶联物 sacituzumab govitecan 的体外和体内活性

Chanhee Han, Emanuele Perrone, Burak Zeybek, Stefania Bellone, Joan Tymon-Rosario, Gary Altwerger, Gulden Menderes, Jacqueline Feinberg, Kaitlin Haines, Mariana Espinal Muller Karger, Anna Bianchi, Luca Zammataro, Aranzazu Manzano, Elena Bonazzoli, Paola Manara, Natalia Buza, Pei Hui, Elena Ratner, 

Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan

过度表达人类滋养层细胞表面标志物 (Trop-2) 的宫颈癌对抗体-药物偶联物 sacituzumab govitecan 高度敏感

Burak Zeybek, Aranzazu Manzano, Anna Bianchi, Elena Bonazzoli, Stefania Bellone, Natalia Buza, Pei Hui, Salvatore Lopez, Emanuele Perrone, Paola Manara, Luca Zammataro, Gary Altwerger, Chanhee Han, Joan Tymon-Rosario, Gulden Menderes, Elena Ratner, Dan-Arin Silasi, Gloria S Huang, Masoud Azodi, Pete

PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers

PI3K 致癌突变介导 HER2/neu 过度表达的妇科癌症对阿法替尼产生耐药性

Elena Bonazzoli, Emiliano Cocco, Salvatore Lopez, Stefania Bellone, Luca Zammataro, Anna Bianchi, Aranzazu Manzano, Ghanshyam Yadav, Paola Manara, Emanuele Perrone, Kaitlin Haines, Mariana Espinal, Katherine Dugan, Gulden Menderes, Gary Altwerger, Chanhee Han, Burak Zeybek, Babak Litkouhi, Elena Rat

PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib

PARP-1 活性 (PAR) 决定宫颈癌对奥拉帕尼的敏感性

Anna Bianchi, Salvatore Lopez, Gary Altwerger, Stefania Bellone, Elena Bonazzoli, Luca Zammataro, Aranzazu Manzano, Paola Manara, Emanuele Perrone, Burak Zeybek, Chanhee Han, Gulden Menderes, Elena Ratner, Dan-Arin Silasi, Gloria S Huang, Masoud Azodi, Justin Y Newberg, Dean C Pavlick, Julia Elvin, 

Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors

原发性、转移性和复发性卵巢癌的突变图谱表明 c-MYC 增益可作为 BET 抑制剂的潜在靶点

Charles Li, Elena Bonazzoli, Stefania Bellone, Jungmin Choi, Weilai Dong, Gulden Menderes, Gary Altwerger, Chanhee Han, Aranzazu Manzano, Anna Bianchi, Francesca Pettinella, Paola Manara, Salvatore Lopez, Ghanshyam Yadav, Francesco Riccio, Luca Zammataro, Burak Zeybek, Yang Yang-Hartwich, Natalia Bu

Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy

宫颈癌全外显子组测序确定激活 ERBB2 和 PIK3CA 突变作为联合治疗的靶点

Luca Zammataro, Salvatore Lopez, Stefania Bellone, Francesca Pettinella, Elena Bonazzoli, Emanuele Perrone, Siming Zhao, Gulden Menderes, Gary Altwerger, Chanhee Han, Burak Zeybek, Anna Bianchi, Aranzazu Manzano, Paola Manara, Emiliano Cocco, Natalia Buza, Pei Hui, Serena Wong, Antonella Ravaggi, El